Clinical Trials on Moderate Chronic Plaque Psoriasis in Korea, Democratic People's Republic of
Total 34 results
-
Bristol-Myers SquibbNot yet recruitingModerate-to-severe Plaque PsoriasisKorea, Republic of
-
Kyowa Kirin Korea Co., Ltd.CompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
GC Cell CorporationRecruitingClinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With PsoriasisModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLCompletedModerate to Severe Plaque PsoriasisKorea, Republic of
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
PfizerCompletedModerate to Severe PsoriasisKorea, Republic of
-
Samsung Bioepis Co., Ltd.CompletedPsoriasis | Moderate to Severe Plaque PsoriasisCzechia, Estonia, Hungary, Korea, Republic of, Latvia, Lithuania, Poland, Ukraine
-
PfizerRecruitingActive Psoriatic Arthritis | Active Ankylosing Spondylitis | Active Moderate to Severe Rheumatoid ArthritisKorea, Republic of
-
UCB Biopharma SRLParexelCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
Johnson & Johnson Pte LtdCompletedPlaque PsoriasisTaiwan, Korea, Republic of, Malaysia, Singapore, Indonesia
-
UCB Biopharma SRLCompletedChronic Plaque PsoriasisUnited States, Australia, Canada, Moldova, Republic of
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Ono Pharmaceutical Co. LtdSuspendedPlaque PsoriasisUnited Kingdom, Moldova, Republic of, Romania
-
Novartis PharmaceuticalsCompletedChronic Plaque Type PsoriasisGermany, United States, Belgium, Korea, Republic of, Spain, Taiwan, Australia, Austria, Italy, Estonia, Israel, Bulgaria, Netherlands, France, Switzerland, Portugal, Slovakia, Norway, United Kingdom, Hungary, Turkey, Canada, Denmark, ...
-
Novartis PharmaceuticalsCompletedChronic Plaque PsoriasisGermany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
-
PfizerCompletedPsoriasis | Plaque PsoriasisSpain, Taiwan, Germany, Korea, Republic of, Belgium, Greece, Hungary, Argentina, Austria, Czech Republic, Italy, Mexico, Thailand
-
Yonsei UniversityCompletedSymptomatic Peripheral Artery Disease With Femoropopliteal Lesions | Moderate or Severe Claudication (Rutherford Category 2 or 3) | Critical Limb Ischemia (Rutherford Category 4 or 5)Korea, Republic of
-
Can-Fite BioPharmaCompletedPlaque PsoriasisIsrael, Serbia, Romania, Croatia, Bosnia and Herzegovina, Bulgaria, Canada, Moldova, Republic of, Poland
-
Seoul National University HospitalChonbuk National University Hospital; Chonnam National University Hospital; Korea... and other collaboratorsTerminatedRheumatoid Arthritis | Chronic Hepatitis B | Juvenile Idiopathic Arthritis | Psoriatic Arthritis | Ankylosing SpondylitisKorea, Republic of
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisUnited States, Korea, Republic of, Germany, France, Taiwan, Japan, Spain, United Kingdom, Poland, Canada
-
Bristol-Myers SquibbRecruitingPlaque PsoriasisAustralia, Mexico, Canada, United Kingdom, France, Argentina, Japan, Poland, Spain, Korea, Republic of, Brazil, Germany, Romania
-
Janssen Research & Development, LLCCompletedPlaque PsoriasisUnited States, Korea, Republic of, Germany, France, Canada, Japan, Taiwan, Spain, United Kingdom, Poland
-
Novartis PharmaceuticalsCompletedPlaque PsoriasisUnited States, Hungary, Malaysia, Czechia, Korea, Republic of, Guatemala, Poland, Vietnam, Canada, Iceland, Slovakia
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisUnited States, Korea, Republic of, Hungary, United Kingdom, Canada, Germany, Poland, Turkey, Taiwan, Spain, Argentina
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisUnited States, Korea, Republic of, Taiwan, Germany, Poland, Brazil, Spain, Hungary, Australia, Canada, Romania
-
Eli Lilly and CompanyCompletedPlaque PsoriasisArgentina, Puerto Rico, United States, Australia, Taiwan, Japan, Hungary, Korea, Republic of, Mexico, Germany, Poland, Romania, Czechia, Canada
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisGermany, United States, Hungary, Italy, Turkey, Korea, Republic of, United Kingdom, China, Taiwan, Poland, Canada, France, Australia, Spain, Argentina, Japan
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisKorea, Republic of, United Kingdom, United States, Poland, Germany, Brazil, Spain, Taiwan, Hungary, Japan, Canada, Argentina, Australia
-
Coherus Biosciences, Inc.CompletedPlaque PsoriasisUnited States, Canada, Bulgaria, Chile, Croatia, Estonia, Georgia, Israel, Italy, Latvia, Moldova, Republic of, Poland, Russian Federation, Slovakia, South Africa, Ukraine
-
Protagonist Therapeutics, Inc.CompletedUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic SevereUnited States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, Serbia, Ukraine
-
Theravance BiopharmaCompletedUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateUnited States, Georgia, Moldova, Republic of, Romania
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland